AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
8.01
-0.11 (-1.35%)
At close: Aug 13, 2026, 4:00 PM EDT
8.00
-0.01 (-0.10%)
Pre-market: Aug 14, 2026, 7:39 AM EDT
AVITA Medical Revenue
AVITA Medical had revenue of $21.70M in the quarter ending June 30, 2026, with 17.83% growth. This brings the company's revenue in the last twelve months to $75.63M, up 1.00% year-over-year. In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth.
Revenue (ttm)
$75.63M
Revenue Growth
+1.00%
P/S Ratio
3.28
Revenue / Employee
$334,650
Employees
226
Market Cap
247.72M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.61M | 7.36M | 11.45% |
| Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
| Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
| Dec 31, 2022 | 34.42M | 5.19M | 17.75% |
| Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
| Jun 30, 2020 | 14.26M | 8.79M | 160.56% |
| Jun 30, 2019 | 5.47M | 4.55M | 489.24% |
| Jun 30, 2018 | 929.00K | 234.89K | 33.84% |
| Jun 30, 2017 | 694.11K | -52.35K | -7.01% |
| Jun 30, 2016 | 746.46K | -188.72K | -20.18% |
| Jun 30, 2015 | 935.18K | -2.16M | -69.75% |
| Jun 30, 2014 | 3.09M | -611.36K | -16.51% |
| Jun 30, 2013 | 3.70M | -1.59M | -30.06% |
| Jun 30, 2012 | 5.29M | 553.99K | 11.69% |
| Jun 30, 2011 | 4.74M | 1.45M | 44.21% |
| Jun 30, 2010 | 3.29M | 643.61K | 24.34% |
| Jun 30, 2009 | 2.64M | 768.38K | 40.97% |
| Jun 30, 2008 | 1.88M | 540.04K | 40.44% |
| Jun 30, 2007 | 1.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 205.31M |
| Pacific Biosciences of California | 159.27M |
| Neuronetics | 155.10M |
| InfuSystem Holdings | 143.34M |
| RxSight | 127.58M |
| Owlet | 114.41M |
| Standard BioTools | 84.60M |
| Profound Medical | 19.09M |
RCEL News
- 1 day ago - AVITA Medical Transcript: Investor update - Transcripts
- 2 days ago - AVITA Medical Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 4 days ago - AVITA Medical to Host Investor Webinar Briefing - GlobeNewsWire
- 6 days ago - Avita Medical price target raised to $8 from $6 at Lake Street - TheFly
- 6 days ago - AVITA Medical Announces Participation at Canaccord Genuity Growth Conference - GlobeNewsWire
- 7 days ago - Avita Medical upgraded to Buy from Neutral at BTIG - TheFly
- 7 days ago - Avita Medical reports Q2 EPS (25c), consensus (39c) - TheFly
- 7 days ago - AVITA Medical Earnings Call Transcript: Q2 2026 - Transcripts